As Vice Chancellor for Health Affairs and CEO of UC Irvine Health, Dr. Federoff oversees the clinical, health education, and research missions. He investigates gene therapy and neurodegenerative diseases. Dr. Federoff has published greater than 250 articles and serves on the editorial boards of five journals. He Chaired the NIH Recombinant DNA Advisory Committee and the Gene Therapy Resource Program for NHLBI. He is President of the American Society for Experimental Neurotherapeutics. Federoff received MS, PhD, and MD degrees from the Albert Einstein College of Medicine, did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School. He is a Fellow of the AAAS, National Academy of Inventors and American Neurological Association.